Positron Emission Tomography (PET) Guided Therapy of Aggressive Lymphomas - Interim PET-Based Outcome Prediction and Treatment Changes in Patients with T Cell Lymphomas Participati... by Hüttmann, Andreas, Müller, Stefan P, Rekowski, Jan, Hertenstein, Bernd, Franzius, Christiane, Franzke, Anke, Bengel, Frank M, Kroschinsky, Frank, Kotzerke, Jörg, La Rosée, Paul, Freesmeyer, Martin, Hoeffkes, Heinz-Gert, Hertel, Andreas, Behringer, Dirk, Mesters, Rolf, Weckesser, Matthias, Mahlmann, Stefan, Haberkorn, Uwe, Martens, Uwe, Prange-Krex, Gabriele, Korfel, Agnieszka, Brenner, Winfried, Giagounidis, Aristoteles, Moeller, Regina, Runde, Volker, Sandmann, Matthias, Hautzel, Hubertus, Wilop, Stefan, Krohn, Thomas, Dürk, Heinz, Strumberg, Dirk, Heike, Michael, Ose, Claudia, Brinkmann, Marcus, Trenn, Guido, Kloke, Otto, Kreisel-Büstgens, Christiane, Dang, Tu-Anh, Heil, Gerhard, Jöckel, Karl-Heinz, Hoelzer, Dieter, Klapper, Wolfram, Duehrsen, Ulrich

Get full text

Prolonged Administration of Interferon-α in Patients With Chronic-Phase Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Before Allogeneic Bone Marrow Transplantation... by Beelen, Dietrich W., Graeven, Ullrich, Elmaagacli, Ahmet H., Niederle, Norbert, Kloke, Otto, Opalka, Bertram, Schaefer, Ulrich W.

Get full text

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2b alone or in combination with interferon γ by OPALKA, B, WANDL, U. B, BECHER, R, KLOBE, O, NAGEL-HIEMKE, M, MORITZ, T, BEER, U, SEEBER, S, NIEDERLE, N

Get full text

Rapamycin antagonizes interleukin-6 mediated growth arrest and differentiation of myeloblastic M1 cells by Kloke, Otto, Kummer, Gerhard, Seeber, Siegfried

Get full text

Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell lines by Siebert, Reiner, Willers, Christoph P., Fosså, Alexander, Kloke, Otto, Nowrousian, Mohammad R., Seeber, Siegfried, Opalka, Bertram

Get full text

Minimal Residual Disease in Patients With Chronic Myelogenous Leukemia Undergoing Long-term Treatment With Recombinant Interferon a-2b Alone or in Combination With Interferon γ by Opalka, Bertram, Wandl, Ursula Brigitte, Becher, Reinhard, Kloke, Otto, Nagel-Hiemke, Marianne, Moritz, Thomas, Beer, Ulrike, Seeber, Siegfried, Niederle, Norbert

Get full text

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma by LINDEMANN, A, HÖFFKEN, K, FRANKS, C. R, HERRMANN, F, MERTELSMANN, R. H, SCHMIDT, R. E, DIEHL, V, KLOKE, O, GAMM, H, HAYUNGS, J, OSTER, W, BÖHM, M, KOLITZ, J. E

Get full text

Tumor necrosis factor α modifies resistance to interferon α in vivo : first clinical data by MORITZ, T, KLOKE, O, NAGEL-HIEMKE, M, KUMMER, G, WANDL, U. B, OPALKA, B, PLAPPERT, B, KEMPENI, J, SEEBER, S, NIEDERLE, N

Get full text

A PvuII Polymorphism of the bcr Region in Patients With Hematopoietic Disorders and Their Families by Opalka, Bertram, Wandl, Ursula, Kloke, Otto, Oberle, Claudia, Koppe, Jutta, Niederle, Norbert, Schmidt, Carl Gottfried

Get full text

Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia by Kloke, Otto, Becher, Reinhard, Niederle, Norbert

Get full text

Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b by Niederle, N, Kloke, O, May, D, Becher, R, Osieka, R, Schmidt, C G

Get full text

Frequency of Clonal B Lymphocytes in Chronic Myelogenous Leukemia Evaluated by Fluorescence In Situ Hybridization by Al-Amin, Amir, Lennartz, Klaus, Runde, Volker, Seeber, Siegfried, Opalka, Bertram, Kloke, Otto

Get full text